Underrepresented Trainee Development Scholarship (UTDS)

The Underrepresented Trainee Development Scholarship (UTDS) is designed to help increase diversity of underrepresented trainees in medicine, to attend the ATS 2026 International Conference (May 15–20, 2026). Awardees will receive recognition and opportunities to network with leaders in pulmonary, critical care, and sleep medicine.

Award Details:

• A travel scholarship
• Certificate of achievement
• Complimentary conference registration
• One-year ATS membership
• Recognition during the Diversity Forum

Applicants must:

• UTDS supports early-career individuals who have faced challenges and obstacles to entry and advancement in medicine, research, and academic health professions. The program focuses on fostering opportunities for trainees from backgrounds with limited representation in these health care fields. We strongly encourage applications from first-generation college graduates, those from economically disadvantaged backgrounds, individuals who identify as women, people with disabilities, and others whose lived experiences reflect limited access to advancement opportunities. Through this scholarship, we aim to build a more inclusive, representative, and supportive professional community that reflects the diversity of the populations we serve.
• Be the first author on an accepted abstract for presentation (case reports excluded).
• Be a current trainee in the U.S., ranging from high school to postdoctoral fellow.
• PhD applicants must be postdocs with five or fewer years of training.

If you have any questions, please contact Adina Roman at aroman@thoracic.org. 

The American Thoracic Society (ATS) is committed to advancing diversity and inclusion in respiratory medicine. The Underrepresented Trainee Development Scholarships (UTDS) support this mission by enabling underrepresented trainees to attend the ATS International Conference. Your generous donation helps ensure that eligible trainees can participate, showcase their work, and grow as future leaders in our field. Thank you for investing in the next generation of respiratory medicine and supporting a more inclusive future